Exane Derivatives’s Alaunos Therapeutics TCRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-271
Closed -$26.5K 915
2022
Q1
$26.5K Buy
+271
New +$26.5K 0.01% 636
2021
Q3
Sell
-302
Closed -$109K 1061
2021
Q2
$109K Hold
302
0.02% 519
2021
Q1
$163K Buy
302
+227
+303% +$122K 0.05% 323
2020
Q4
$28.3K Buy
+75
New +$28.3K 0.01% 487